Açıklama
Summary of current evidence and future directions for microbiome-targeted therapies in pouchitis and ulcerative colitis are presented, identifying key knowledge gaps.
Cite This Figure
![Figure 7: Summary of current evidence and future directions for microbiome-targeted therapies in pouchitis and ulcerative colitis are presented, identifying key knowledge gaps.]() > Source: Jean-Frédéric LeBlanc et al. "The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.." *Nutrients*, 2021. PMID: [34071065](https://pubmed.ncbi.nlm.nih.gov/34071065/)
<figure> <img src="" alt="Summary of current evidence and future directions for microbiome-targeted therapies in pouchitis and ulcerative colitis are presented, identifying key knowledge gaps." /> <figcaption>Figure 7. Summary of current evidence and future directions for microbiome-targeted therapies in pouchitis and ulcerative colitis are presented, identifying key knowledge gaps.<br> Source: Jean-Frédéric LeBlanc et al. "The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34071065/">34071065</a></figcaption> </figure>